Abstract
Objective
Validation of a novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration (CVVHDF).
Design and setting
Prospective cohort trial in medicosurgical intensive care units of two university-affiliated teaching institutions.
Patients
Participants were patients at high risk for bleeding, with renal failure requiring CVVHDF without heparin. Fourteen patients completed the study.
Intervention
A convection-based citrate anticoagulation CVVHDF regimen using an isotonic replacement fluid containing citrate administered in predilution. A neutralizing solution of calcium chloride and magnesium sulfate was infused at the end of the circuit. Blood flow rate was set and kept at 125 ml/min, and the flow rate of the replacement fluid was initiated at 1250 ml/h and adjusted thereafter according to the monitoring of blood activated coagulation time (ACT), with a target between 180 to 220 s.
Measurements and results
The average filter time-life was 44 h. Thrombosis of the proximal portion of the circuit (which was not anticoagulated) was the main reason for technique failure. A mean urea clearance of 21 ml/min was obtained. Electrolytes and acid-base balance were both well maintained. Six percent (16/287) of Cai readings less than 0.3 mmol/l were associated with very high ACT levels (>300 s).
Conclusions
This regimen is shown to be safe, efficacious, and convenient. Citrate anticoagulation should be monitored using postfilter ACT and/or ionized calcium with respective targets of 200–250 s or 0.3–0.4 mmol/l.
Similar content being viewed by others
References
Metha R, McDonald B, Aguilar M, Ward D (1990) Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976–981
Kutsogiannis D, Mayers I, Chin W, Gibney R (2000) Regional Citrate Anticoagulation in Continuous Venovenous hemodiafiltration. Am J Kidney Dis 35:802–811
Palsson R, Niles J (1999) Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney int 55:1991–1997
Tolwani A, Campbell R, Schenk M, Allon M, Warnock D (2001) Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 60:370–374
Hocken A, Hurst P (1987) Citrate regional anticoagulation in hemodialysis. Nephron 46:7–10
Janssen M, Huijgens P, Bouman A, Oe P, Van der Meulen J (1994) Citrate anticoagulation and divalent cations in hemodialysis. Blood Purif 12:308–316
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dorval, M., Madore, F., Courteau, S. et al. A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration. Intensive Care Med 29, 1186–1189 (2003). https://doi.org/10.1007/s00134-003-1801-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-003-1801-4